Surgery Partners, Inc. (SGRY)
| Market Cap | 3.47B +69.3% |
| Revenue (ttm) | 3.36B +2.2% |
| Net Income | -87.00M |
| EPS | -0.68 |
| Shares Out | 129.67M |
| PE Ratio | n/a |
| Forward PE | 121.77 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,607,414 |
| Open | 26.75 |
| Previous Close | 26.95 |
| Day's Range | 26.62 - 26.95 |
| 52-Week Range | 11.41 - 27.23 |
| Beta | 1.88 |
| Analysts | Hold |
| Price Target | 24.40 (-8.92%) |
| Earnings Date | Nov 9, 2026 |
About SGRY
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care faciliti... [Read more]
Financial Performance
In 2025, Surgery Partners's revenue was $3.31 billion, an increase of 6.24% compared to the previous year's $3.11 billion. Losses were -$77.90 million, -53.66% less than in 2024.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for SGRY stock is "Hold." The 12-month stock price target is $24.4, which is a decrease of -8.92% from the latest price.
News
Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.'s 7.250% Senior Notes due 2032
BRENTWOOD, Tenn., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (“Surgery Partners”) (Nasdaq: SGRY) announced today that its indirect wholly owned subsidiary, Surgery Center Holdings, Inc. ...
Surgery Partners Proxy statement: Proxy filing
Surgery Partners filed a proxy statement on November 16, 2026, providing details for shareholder voting and corporate governance matters.
Surgery Partners price target raised to $25 from $23.50 at TD Cowen
TD Cowen raised the firm’s price target on Surgery Partners (SGRY) to $25 from $23.50 and keeps a Hold rating on the shares. The firm updated its model following Q3…
SGRY Securities Notice: Surgery Partners Shareholders are Notified to Contact BFA Law about its Investigation into the $23.50 per Share Take-Private Merger
NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: ...
Surgery Partners downgraded to Neutral from Outperform at Mizuho
Mizuho downgraded Surgery Partners (SGRY) to Neutral from Outperform with a price target of $25, up from $19. The firm cites the company’s revised takeover proposal of $25 per share…
Surgery Partners reports Q3 adjusted EPS 16c, consensus 12c
Reports Q3 revenue $815.3M, consensus $814.7M. Same-facility revenues increased 6% for the third quarter. Eric Evans, Chief Executive Officer, stated, “Our financial results in the third quarter refle...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Lumentum Holdings Inc. (Nasdaq – LITE), ARRAY Technologies, Inc. (NASDAQ – ARRY), Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC)
BALA CYNWYD, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j...
Surgery Partners, Inc. Announces Third Quarter 2026 Results
BRENTWOOD, Tenn., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announc...
Surgery Partners Earnings release: Q3 2026
Surgery Partners released its Q3 2026 earnings on November 9, 2026, summarizing the period's financial results.
Surgery Partners Quarterly report: Q3 2026
Surgery Partners has published its Q3 2026 quarterly earnings report on November 9, 2026.
Surgery Partners turned down $28 per share bid from UnitedHealth, Bloomberg says
10:56 EST Surgery Partners (SGRY) turned down $28 per share bid from UnitedHealth (UNH), Bloomberg says
Surgery Partners rejected $28 per share bid from UNH, Bloomberg says
UnitedHealth (UNH) offered $28 per share to acquire Surgery Partners (SGRY), which was rejected over concerns about the complexity of the deal, John Tozzi and Michelle Davis of Bloomberg report,…
Surgery Partners, HealthSpan increase merger consideration to $25 per share
Surgery Partners (SGRY) and HealthSpan Partners announced an amendment to its previously announced merger agreement. The amendment follows Surgery Partners’ receipt of an unsolicited competing proposa...
Surgery Partners and HealthSpan Partners Announce Amended Merger Agreement, Following Receipt of Unsolicited Proposal
BRENTWOOD, Tenn. & CINCINNATI--(BUSINESS WIRE)--Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, and HealthSpan P...
Surgery Partners Proxy statement: Proxy filing
Surgery Partners filed a proxy statement on November 9, 2026, providing details for shareholder voting and corporate governance matters.
Surgery Partners Proxy statement: Proxy filing
Surgery Partners filed a proxy statement on November 9, 2026, providing details for shareholder voting and corporate governance matters.
Surgery Partners Proxy statement: Proxy filing
Surgery Partners filed a proxy statement on November 9, 2026, providing details for shareholder voting and corporate governance matters.
SGRY Investigation Reminder: Surgery Partners Shareholders Notified of Investigation into $23.50 per Share Merger – Contact BFA Law
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: ...
SGRY Legal Notice: Surgery Partners Shareholders Are Notified to Contact BFA Law About the Ongoing Investigation Into the $23.50 Per Share Merger
NEW YORK--(BUSINESS WIRE)---- $SGRY #BFA--Surgery Partners Shareholders are Notified to Contact BFA Law About the Ongoing Investigation into the $23.50 per Share Merger.
Surgery Partners downgraded to Hold from Buy at TD Cowen
TD Cowen downgraded Surgery Partners (SGRY) to Hold from Buy with a $23.50 price target following the company’s agreement to be acquired by HealthSpan Partners, an affiliate of Bon Secours…
SGRY Investigation Reminder: Surgery Partners' $23.50 per Share Merger Is Under Investigation – Contact BFA Law if You Hold Shares
NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that it is investigating the going private merger whereby Surgery Partners, Inc. (NASDAQ: ...
SGRY Merger Notice: BFA Law Notifies Surgery Partners Shareholders of the Ongoing Investigation into the $23.50 per Share Merger
BFA Law is investigating the $23.50 per share merger, announced on October 26, 2026, in which Bon Secours Mercy Health, Inc. is set to acquire Surgery Partners, while Surgery Partners' largest stockho...
Surgery Partners Proxy statement: Proxy filing
Surgery Partners filed a proxy statement on October 28, 2026, providing details for shareholder voting and corporate governance matters.
SGRY Stock Notification: Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law
NEW YORK--(BUSINESS WIRE)---- $SGRY #BFA--Surgery Partners, Inc. is being Investigated after the $23.50 per share Merger Deal Announced – Investors are Alerted to Contact BFA Law.
Surgery Partners downgraded to Neutral from Buy at UBS
UBS analyst AJ Rice downgraded Surgery Partners (SGRY) to Neutral from Buy with a $23.50 price target following the company’s agreement to be acquired by HealthSpan Partners, an affiliate of…